(Reuters) -Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year outlook and updates on an experimental obesity drug to gauge the U.S. drugmaker's longer-term health. Lilly's weight-loss drug Zepbound leads the U.S. market and has faced less competition...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

03:56 PM EDT, 07/29/2025 (MT Newswires) -- Rudy F De Leon, Director, on July 28, 2025, sold 5,490 shares in General Dynamics ( GD ) for $1,717,312. Following the Form 4 filing with the SEC, De Leon has control over a total of 5,483 common shares of the company, with 5,483 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/40533/000095017025099603/xslF345X05/ownership.xml Price: 314.12, Change:...

July 29 (Reuters) - Investors and analysts say they expect Eli Lilly ( LLY ) to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year outlook and updates on an experimental obesity drug to gauge the U.S. drugmaker's longer-term health. Lilly's weight-loss drug Zepbound leads the U.S....